{"id":"n_2jy5dreypqi27xmsoopq","seq":12522938,"kind":"article","title":"El pertuzumab de Biocon recibe la autorización de comercialización en la UE. Primer biosimilar autorizado mediante el nu","url":"https://www.europapress.es/comunicados/internacional-00907/noticia-comunicado-pertuzumab-biocon-recibe-autorizacion-comercializacion-ue-primer-biosimilar-autorizado-nu-20261118152217.html","published":"2026-11-18T14:22:00Z","seen":"2026-11-18T15:53:05Z","lang":"es","country":"ES","source":{"id":"europapress.es","name":"europapress.es","domain":"europapress.es"},"via":"gdelt-gkg-translingual","topics":["economy","science","health"],"story":"st_cxeaggv2mk6jarsf5lpq","category":"economy-business","category_p":0.43,"category2":"science-technology","sentiment":"positive","tone":0.19,"political":0.13}